Serious Adverse Event Závažná nežádoucí příhoda Sample Clauses

Serious Adverse Event Závažná nežádoucí příhoda. 2.12.1 Means any untoward medical occurrence that at any dose according to the §3 clauses 3 – 6 Act No. 378/2007 Coll., on Drugs, as amended : Jedná se o jakýkoli neočekávaný lékařský nález, který xxx xxxxxxxx xxxxx (xxxxx §0 odstavců 3–6 zákona č. 378/2007 Sb., o léčivech, ve znění pozdějších předpisů): A) results in death, A) vede ke smrti, B) is life-threatening, B) je život ohrožující, C) requires inpatient hospitalisation or prolongation of existing hospitalisation, C) vyžaduje hospitalizaci pacienta nebo prodloužení stávající hospitalizace, D) results in persistent or significant disability / incapacity, D) vede k trvalému či významnému zdravotnímu postižení či pracovní neschopnosti, E) is a congenital anomaly / birth defect. E) představuje vrozenou anomálii či vrozenou vadu.
AutoNDA by SimpleDocs
Serious Adverse Event Závažná nežádoucí příhoda. 2.11.1 Any untoward medical occurrence that at any dose according to the §3 clauses 3 – 6 Act No. 378/2007 Coll., on Drugs, as amended : Jakýkoliv neočekávaný lékařský nález, který v jakékoliv dávce (podle §3 odstavce 3 – 6 zákona č. 378/2007 Sb., o léčivech, ve znění pozdějších předpisů):

Related to Serious Adverse Event Závažná nežádoucí příhoda

  • Professional Development; Adverse Consequences of School Exclusion; Student Behavior The Board President or Superintendent, or their designees, will make reasonable efforts to provide ongoing professional development to Board members about the adverse consequences of school exclusion and justice-system involvement, effective classroom management strategies, culturally responsive discipline, appropriate and available supportive services for the promotion of student attendance and engagement, and developmentally appropriate disciplinary methods that promote positive and healthy school climates, i.e., Senate Bill 100 training topics. Board Self-Evaluation The Board will conduct periodic self-evaluations with the goal of continuous improvement. New Board Member Orientation The orientation process for newly elected or appointed Board members includes:

  • Adverse Event Reporting Both Parties acknowledge the obligation to comply with the Protocol and / or applicable regulations governing the collection and reporting of adverse events of which they may become aware during the course of the Clinical Trial. Both Parties agree to fulfil and ensure that their Agents fulfil regulatory requirements with respect to the reporting of adverse events.

  • Adverse Events Subsequent to the date hereof, there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities generally on the New York Stock Exchange, the NASDAQ National Market or the NASDAQ Global Market, (ii) a general moratorium on commercial banking activities in the People’s Republic of China or New York, (iii) the outbreak or escalation of hostilities involving the United States or the People’s Republic of China or the declaration by the United States or the People’s Republic of China of a national emergency or war if the effect of any such event specified in this clause (iii) in your reasonable judgment makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus, or (iv) such a material adverse change in general economic, political, financial or international conditions affecting financial markets in the United States or the People’s Republic of China having a material adverse impact on trading prices of securities in general, as, in your reasonable judgment, makes it impracticable or inadvisable to proceed with the public offering of the Shares or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus.

  • Serious Illness Should a participant be unable to take the leave when scheduled because of serious injury or illness occurring before commencement of the leave, he/she may cancel the leave and receive payment as in Article 12.8.3.9 or, with the consent of the College, defer the leave to a time mutually agreeable, not to exceed one (1) year.

  • Serious Health Condition An illness, injury, impairment, or physical or mental condition which warrants the participation of a family member to provide care during a period of treatment or supervision and involves either inpatient care in a hospital, hospice or residential health care facility or continuing treatment or continuing supervision by a health care provider (e.g. physician or surgeon) as defined by state and federal law.

  • Infectious Disease Where an employee produces documentary evidence that:

  • FLORIDA CONVICTED/SUSPENDED/DISCRIMINATORY COMPLAINTS By submission of an offer, the respondent affirms that it is not currently listed in the Florida Department of Management Services Convicted/Suspended/Discriminatory Complaint Vendor List.

  • Independence from Material Breach Determination Except as set forth in Section X.D.1.c, these provisions for payment of Stipulated Penalties shall not affect or otherwise set a standard for OIG’s decision that CHSI has materially breached this CIA, which decision shall be made at OIG’s discretion and shall be governed by the provisions in Section X.D, below.

  • Diagnostic Assessment 6.3.1 Boards shall provide a list of pre-approved assessment tools consistent with their Board improvement plan for student achievement and which is compliant with Ministry of Education PPM (PPM 155: Diagnostic Assessment in Support of Student Learning, date of issue January 7, 2013).

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

Time is Money Join Law Insider Premium to draft better contracts faster.